Repro USMLE step 1 9-1 (2) Flashcards
This infant has microcephaly, hearing loss, hepatosplenomegaly, and a petechial rash. Furthermore, the mother discloses that she had fever, sore throat, and fatigue early in her pregnancy. In this setting, the most likely diagnosis is?
a congenital cytomegalovirus (CMV) infection. Pregnant women can become infected with CMV through sexual contact or organ transplantation. Pregnant women with CMV infection are typically free of symptoms but may have a mononucleosis-like illness, as described by this infant’s mother. Fetuses exposed to CMV during the first trimester may experience intrauterine growth retardation in addition to central nervous system damage with hearing and sight impairments. Intellectual disability can occur along with microcephaly. A classic feature of CMV is periventricular calcifications, which may be observed on a head CT scan.
CMV is part of a group of microbes that cause ToRCHeS infections, alongside Toxoplasma gondii, Rubella, Cytomegalovirus, HIV, Herpes simplex virus-2, and Syphilis. Most ToRCHeS infections are transmitted from?
mother to fetus transplacentally; however, transmission during delivery (particularly with herpes simplex virus-2) is also possible in some cases. Any ToRCHeS infection can result in hepatosplenomegaly, jaundice, thrombocytopenia (petechial skin rash), and growth retardation.
Congenitally acquired rubella is associated with cataracts, hearing loss, and congenital heart disease.
Congenitally acquired herpes simplex virus is associated with neonatal meningoencephalitis and vesicular, herpetic lesions.
Congenitally acquired HIV presents as?
recurrent infections and chronic diarrhea in neonates.
Congenitally acquired syphilis often results in stillbirth and hydrops fetalis. If the infant survives, he or she will have notched teeth, a saddle nose, saber shins, and sensorineural deafness.
Congenital CMV infection manifests in neonates as?
hearing loss, seizures, petechial rash, microcephaly, and evidence of periventricular calcifications on CT of the head. Maternal manifestation may include a mononucleosis-like illness during pregnancy.
This child is brought to the pediatrics clinic, and a medical student is performing a well-child examination. The medical student’s initial observations are provided, and the question asks for another developmental milestone associated with those observations.
Developmental milestones can be used by pediatricians to determine an infant’s or child’s motor, social, and verbal/cognitive age. Infants or children who are not meeting milestones may need assessment for potential developmental delay.
The first milestone mentioned is stranger anxiety, observed when the medical student walks in the room and the infant begins to cry and hide behind his mother. Stranger anxiety typically begins around 6 months of age. Furthermore, the infant is seen passing toys from hand to hand and sitting alone without his mother’s help, both milestones that are also present in infants around 6 months of age. Given these findings, we can be confident that this infant is about 6 months old. The answer choice that most accurately aligns with this infant’s development is?
rolling over. Another milestone seen in 6-month-old infants is the loss of the palmar primitive reflex.
Taking a first step typically occurs in infants between 10 and 12 months of age. Responding to his (or her) own name typically occurs in an infant at around 9 months of age. Loss of the Babinski sign typically occurs in infants around 12 months of age. Saying “ma-ma” and “da-da” with meaning typically occurs in infants around 10 months of age.
Developmental milestones are useful for determining an infant’s or child’s motor, social, and verbal/cognitive progress. At 6 months of age, children typically display ?
stranger anxiety, loss of the palmar primitive reflex, the ability to roll and sit on their own, and the ability to pass toys from hand to hand.
This patient presents with irregular menstrual cycles, hirsutism, and possible diabetes. She is most likely suffering from polycystic ovarian syndrome (PCOS), one of the most common endocrinopathies in women. In addition to hirsutism, PCOS is associated with infertility (secondary to oligo-ovulation), insulin resistance, hyperandrogenism, and obesity.
Symptoms of PCOS often develop after menarche and seem to be caused by intraovarian androgen excess, which causes anovulation and the formation of multiple ovarian cysts. These cysts stimulate excessive growth of follicles and hinder the maturation of a dominant follicle.
Multiple therapies are often required. Of note, oral contraceptive pills (OCPs) are the first-line treatment for PCOS. If treatment with OCPs yields unacceptable cosmetic results after six months, an antiandrogen, such as?
spironolactone, is added to treat hirsutism.
Spironolactone acts by blocking androgen receptors and inhibiting androgen biosynthesis; it is also a diuretic. Additional drugs for PCOS include gonadotropin analogs and clomiphene.
Ganirelix is a GnRH antagonist which would cause ovarian suppression. Furosemide is a diuretic drug that would have no efficacy against this patient’s hirsutism. Minoxidil would cause an increase in hair growth. Estrogen would not help this patient, whose estrogen levels are most likely already elevated due to her condition.
Polycystic ovarian syndrome is characterized by elevated testosterone levels (resulting in hirsutism, anovulation), high levels of insulin, and high levels of luteinizing hormone. It may be treated with?
spironolactone, oral contraceptives, gonadotropin analogs, and clomiphene.
This patient presents with burning on urination, malodorous green discharge, and erythematous vaginal mucosa. The presence of flagellated trophozoites on a wet mount of the discharge is observed confirming a diagnosis of trichomoniasis.
Trichomoniasis is a sexually transmitted infection (STI) characterized by vaginal itching, burning on urination, foul-smelling green discharge, and vaginal erythema. Vaginal pH may also be elevated (>4.5). It is caused by the protozoan parasite Trichomonas vaginalis.Treatment consists of a one-time dose of ?
metronidazole for the patient and her sexual partner. Partner treatment is necessary with this infection because in male patients this organism can cause asymptomatic urethritis.
Ceftriaxone and azithromycin, for both the patient alone and with her partner, is the treatment regimen for chlamydia or gonorrhea. Chlamydia or gonorrhea infection usually presents with purulent vaginal discharge originating from an inflamed cervix. These infections may be, accompanied by cervical motion tenderness if they ascend into the upper genital tract, causing pelvic inflammatory disease. Fluconazole would be used to treat?
a yeast infection, such as candida. Candida vaginitis would present with a thick, cottage cheese-like, white discharge and KOH prep would reveal pseudohyphae instead of motile protozoa. Trichomonas is an STI, and although metronidazole is the correct treatment, it cannot be given to the patient alone. Both the patient and her partner need to be treated with metronidazole.
This boy with an opening of the urethra on the dorsal aspect of the penis has simple epispadias (Think of dorsal/ventral with the penis being oriented superiorly against the lower abdomen–dorsal is the top of the penis, ventral is the bottom). This is a rare congenital defect caused by abnormal development of the genital tubercle. Depending on the level at which the paired primordia of the genital tubercle fuse, the defect may range from simple epispadias to bladder and bowel exstrophy. In female fetuses, the genital tubercle develops into?
the glans clitoris during gestation. Epispadias in a female can result in a bifid clitoris and a urethral cleft, leading to incontinence.
Hypospadias is due to abnormal development of the urogenital folds which form the labia minora in females. The labia majora and the scrotum are derived from?
the labioscrotal swelling. The uterus is derived from the paramesonephric ducts. The inferior two-thirds of the vagina is derived from the vaginal plate of the urogenital sinus. The uterus, uterine tubes, cervix and superior third of the vagina is derived from the paramesonephric ducts. In males, this structure is lost.
Epispadias results from a defect in the development of the genital tubercle, which is the embryologic precursor of ?
the glans penis and the glans clitoris
This patient has a painful penile ulcer and inguinal lymphadenopathy with purulent discharge, a classic presentation of chancroid. Chancroid is a sexually transmitted disease caused by Haemophilus ducreyi, which is?
a gram-negative coccobacillus.
The genital lesions may begin as small papules that rapidly evolve into painful ulcers with erythematous bases that bleed easily with mechanical manipulation. Painful, swollen inguinal lymph nodes, often unilateral, develop in about 30% of infected persons. In 50% of these patients, the swollen lymph nodes will rupture and drain pus. An example of chancroid infection is displayed in the image below. Treatment options for chancroid include azithromycin, ceftriaxone, and ciprofloxacin.
This child has been raised as a girl, although ambiguous genitalia were present at birth. Now that she is reaching puberty, her body is changing in ways that are inconsistent with that gender assignment. She is experiencing changes in her body mass and voice in addition to a lack of menstruation. These findings are most consistent with a diagnosis of?
5a-reductase deficiency. 5a-Reductase converts testosterone to dihydrotestosterone. Dihydrotestosterone is required for the development of the penis and scrotum during embryogenesis. An infant with 5a-reductase deficiency may be phenotypically female, with normal levels of testosterone, estrogen, and luteinizing hormone; however, an infant with this deficiency is genotypically male. The dramatic increase in testosterone levels during puberty causes the external genitalia to be masculinized and the development of male secondary sexual characteristics. Failure to menstruate is commonly reported by patients with 5a-reductase deficiency.